NASDAQ:SPRY | Operating Income | ARS Pharmaceuticals, Inc.

Complete source-backed operating income history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$61.47M
2026-03-31-$60.15M
2025-12-31-$41.47M
2025-09-30-$53.19M
2025-06-30-$47.61M
2025-03-31-$37.18M
2024-12-31$47.2M
2024-09-30-$21.75M
2024-06-30-$15.34M
2024-03-31-$13.19M
2023-12-31-$10.23M
2023-09-30-$17.98M
2023-06-30-$20.6M
2023-03-31-$18.71M
2022-12-31-$15.44M
2022-09-30-$6.63M
2022-06-30-$6.34M
2022-03-31-$7.1M
2021-12-31$46.62M
2021-09-30-$22.68M
2021-06-30-$24.51M
2021-03-31-$18.89M
2020-12-31-$13.1M
2020-09-30-$8.11M
2020-06-30-$6.46M
2020-03-31-$5.24M

Annual Operating Income

DateOperating Income
2025-12-31-$179.45M
2024-12-31-$3.08M
2023-12-31-$67.52M
2022-12-31-$35.52M
2021-12-31-$19.45M
2020-12-31-$32.92M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.